Analytical Data
-
Gene name
PLAC8L1
- Application
-
Alternative Names
PLAC8L1; PLAC8-like protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A1L4L8
-
Expression Region
1-177 aa
-
AA Sequence
MNWFGSNFFR CPEDLSLLNI YSPLLSHMSS EDEHFISNLR GHVPASAVVK QPVRGASGRT TITAIVQTGG GWSTGLFSVC RDRRICFCGL FCPMCLECDI ARHYGECLCW PLLPGSTFAL RIGTRERHKI QGTLCEDWLA VHCCWAFSIC QVARELKMRT SQVYEICAVP MTKDTLV
-
Molecular Weight
19.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLAC8L1, a relatively novel protein implicated in various biological processes, has gained attention in recent years due to its significant role in cell signaling, immune response, and potential implications in cancer biology. Located on chromosome 8, the PLAC8L1 gene encodes a protein that is believed to participate in the regulation of cell proliferation and apoptosis. Investigations into its expression patterns have revealed that PLAC8L1 is differentially expressed in numerous tissues, with notable upregulation in certain tumors, suggesting a potential role as a biomarker for cancer progression. Furthermore, preliminary studies indicate that PLAC8L1 may interact with critical signaling pathways, including those involved in the modulation of immune responses, hinting at its potential function in inflammatory diseases. Given these observations, researchers are increasingly focusing on the recombinant expression of PLAC8L1 to understand its structure-function relationships, post-translational modifications, and interactions with other biomolecules. This understanding could pave the way for novel therapeutic strategies targeting PLAC8L1 in cancer and autoimmunity, as well as contribute to the growing field of personalized medicine. Overall, PLAC8L1 represents a promising target for future research, with the potential to unlock new insights into its role in health and disease.
